The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.
Open accessAbstract
This report describes the isolation and recombinant expression of a cDNA clone encoding HER4, the fourth member of the human epidermal growth factor receptor (EGFR) family. The HER4/erbB4 gene encodes a 180-kDa transmembrane tyrosine kinase (HER4/p180erbB4) whose extracellular domain is most similar to the orphan receptor HER3/p160erbB3, whereas its cytoplasmic kinase domain exhibits 79% and 77% identity with EGFR and HER2/p185erbB2, respectively. HER4 is most predominantly expressed in several breast carcinoma cell lines, and in normal skeletal muscle, heart, pituitary, brain, and cerebellum. In addition, we describe the partial purification of a heparin-binding HER4-stimulatory factor from HepG2 cells. This protein was found to specifically stimulate the intrinsic tyrosine kinase activity of HER4/p180erbB4 while having no direct effect on the phosphorylation of EGFR, HER2, or HER3. Furthermore, this heparin-binding protein induces phenotypic differentiation, and tyrosine phosphorylation, of a human mammary tumor cell line that overexpresses both HER4 and HER2. These findings suggest that this ligand-receptor interaction may play a role in the growth and differentiation of some normal and transformed cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains
Hanks, S. K., Quinn, A. M., & Hunter, T. (1988) · Science · doi:10.1126/science.3291115 · Cited by 5,039
Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A., Schlessinger, J., et al. (1984) · Nature · doi:10.1038/309418a0 · Cited by 2,752
Aaronson, S. A. (1991) · Science · doi:10.1126/science.1659742 · Cited by 2,028
Coussens, L., Yang-Feng, T. L., Liao, Y.-C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., et al. (1985) · Science · doi:10.1126/science.2999974 · Cited by 1,814
Identification of Heregulin, a Specific Activator of p185 erbB2
Holmes, W. E., Sliwkowski, M. X., Akita, R. W., Henzel, W. J., Lee, J., Park, J. W., Yansura, D., Abadi, N., Raab, H., Lewis, G. D., et al. (1992) · Science · doi:10.1126/science.256.5060.1205 · Cited by 962
Kraus, M. H., Issing, W., Miki, T., Popescu, N. C., & Aaronson, S. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9193 · Cited by 737
Kraus, M. H., Popescu, N. C., Amsbaugh, S. C., & King, C. R. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04797.x · Cited by 617
Wen, D., Peles, E., Cupples, R., Suggs, S. V., Bacus, S. S., Luo, Y., Trail, G., Hu, S., Silbiger, S. M., Levy, R. B., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90456-m · Cited by 577
Lai, C., & Lemke, G. (1991) · Neuron · doi:10.1016/0896-6273(91)90167-x · Cited by 443
Cited by
Epidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
Graus-Porta, D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.7.1647 · Cited by 1,590
Moasser, M. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210477 · Cited by 1,219
Targeting HER2-positive breast cancer: advances and future directions
Swain, S. M., Shastry, M., & Hamilton, E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00579-0 · Cited by 1,160
Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor
Gassmann, M., Casagranda, F., Orioli, D., Simon, H., Lai, C., Klein, R., & Lemke, G. (1995) · Nature · doi:10.1038/378390a0 · Cited by 1,148
Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology*
Auersperg, N., Wong, A. S. T., Choi, K.-C., Kang, S. K., & Leung, P. C. K. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0422 · Cited by 1,046
The ERBB network: at last, cancer therapy meets systems biology
Yarden, Y., & Pines, G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3309 · Cited by 988
Specificity within the EGF family/ErbB receptor family signaling network
Riese, D. J., & Stern, D. F. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199801)20:1<41::aid-bies7>3.0.co;2-v · Cited by 809
Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B. J., Sela, M., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00603.x · Cited by 769
Prenzel, N., Fischer, O. M., Streit, S., Hart, S., & Ullrich, A. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080011 · Cited by 673
Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase
Rabindran, S. K., Discafani, C. M., Rosfjord, E. C., Baxter, M., Floyd, M. B., Golas, J., Hallett, W. A., Johnson, B. D., Nilakantan, R., Overbeek, E., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2868 · Cited by 639
Garrett, T. P. J., McKern, N. M., Lou, M., Elleman, T. C., Adams, T. E., Lovrecz, G. O., Kofler, M., Jorissen, R. N., Nice, E. C., Burgess, A. W., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00048-0 · Cited by 613
Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer
Witton, C. J., Reeves, J. R., Going, J. J., Cooke, T. G., & Bartlett, J. M. (2003) · The Journal of Pathology · doi:10.1002/path.1370 · Cited by 590
ErbB receptors: from oncogenes to targeted cancer therapies
Zhang, H., Berezov, A., Wang, Q., Zhang, G., Drebin, J., Murali, R., & Greene, M. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32278 · Cited by 574
Biochemical and Clinical Implications of the ErbB/HER Signaling Network of Growth Factor Receptors
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60784-8 · Cited by 540
Neuregulins Promote Survival and Growth of Cardiac Myocytes
Zhao, Y.-Y., Sawyer, D. R., Baliga, R. R., Opel, D. J., Han, X., Marchionni, M. A., & Kelly, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10261 · Cited by 504
Glial growth factor restricts mammalian neural crest stem cells to a glial fate
SHAH, N. (1994) · Cell · doi:10.1016/0092-8674(94)90150-3 · Cited by 495
Erickson, S. L., O’Shea, K. S., Ghaboosi, N., Loverro, L., Frantz, G., Bauer, M., Lu, L. H., & Moore, M. W. (1997) · Development · doi:10.1242/dev.124.24.4999 · Cited by 467
All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired
Baulida, J., Kraus, M. H., Alimandi, M., Fiore, P. P. D., & Carpenter, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5251 · Cited by 454
Goldenberg, M. M. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88288-0 · Cited by 453
ERBB2 oncogene in human breast cancer and its clinical significance
Révillion, F., Bonneterre, J., & Peyrat, J. P. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10157-5 · Cited by 448
Dong, Z., Brennan, A., Liu, N., Yarden, Y., Lefkowitz, G., Mirsky, R., & Jessen, K. R. (1995) · Neuron · doi:10.1016/0896-6273(95)90147-7 · Cited by 445
Siegel, P. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2149 · Cited by 442
Heregulin induces tyrosine phosphorylation of HER4/p180erbB4
Plowman, G. D., Green, J. M., Culouscou, J.-M., Carlton, G. W., Rothwell, V. M., & Buckley, S. (1993) · Nature · doi:10.1038/366473a0 · Cited by 441
Self-citationThe mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.
Luetteke, N. C., Phillips, H. K., Qiu, T. H., Copeland, N. G., Earp, H. S., Jenkins, N. A., & Lee, D. C. (1994) · Genes & Development · doi:10.1101/gad.8.4.399 · Cited by 441
Heregulin‐dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3.
Wallasch, C., Weiss, F. U., Niederfellner, G., Jallal, B., Issing, W., & Ullrich, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00101.x · Cited by 406
Autocrine, paracrine and juxtacrine signaling by EGFR ligands
Singh, A. B., & Harris, R. C. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.026 · Cited by 400
The EGFRvIII variant in glioblastoma multiforme
Gan, H. K., Kaye, A. H., & Luwor, R. B. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.12.005 · Cited by 396
The Cytogenesis and Pathogenesis of Pituitary Adenomas*
Asa, S. L., & Ezzat, S. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0350 · Cited by 388
Neuregulin-3 (NRG3): A novel neural tissue-enriched protein that binds and activates ErbB4
Zhang, D., Sliwkowski, M. X., Mark, M., Frantz, G., Akita, R., Sun, Y., Hillan, K., Crowley, C., Brush, J., & Godowski, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9562 · Cited by 383
Neuregulin and erbB Receptors Play a Critical Role in Neuronal Migration
Rio, C., Rieff, H. I., Qi, P., & Corfas, G. (1997) · Neuron · doi:10.1016/s0896-6273(00)80346-3 · Cited by 382
Regulation of Neuregulin Signaling by PSD-95 Interacting with ErbB4 at CNS Synapses
Huang, Y. Z., Won, S., Ali, D. W., Wang, Q., Tanowitz, M., Du, Q. S., Pelkey, K. A., Yang, D. J., Xiong, W. C., Salter, M. W., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)81176-9 · Cited by 381
The Cellular Response to Neuregulins Is Governed by Complex Interactions of the erbB Receptor Family
Riese, D. J., van Raaij, T. M., Plowman, G. D., Andrews, G. C., & Stern, D. F. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5770 · Cited by 368
Self-citationThe erbB3 gene product is a receptor for heregulin.
Carraway, K. L., Sliwkowski, M. X., Akita, R., Platko, J. V., Guy, P. M., Nuijens, A., Diamonti, A. J., Vandlen, R. L., Cantley, L. C., & Cerione, R. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36789-3 · Cited by 362
Earp, H. S., Dawson, T. L., Li, X., & Yu, H. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00694752 · Cited by 361
Prigent, S. A., & Gullick, W. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06577.x · Cited by 359
Xu, W., Mimnaugh, E., Rosser, M. F. N., Nicchitta, C., Marcu, M., Yarden, Y., & Neckers, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006864200 · Cited by 353
Sardi, S. P., Murtie, J., Koirala, S., Patten, B. A., & Corfas, G. (2006) · Cell · doi:10.1016/j.cell.2006.07.037 · Cited by 349
Heparin-Binding EGF-Like Growth Factor
National Cancer Institute (2020) · Definitions · doi:10.32388/hz52we · Cited by 345
Elenius, K. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1268 · Cited by 343
Carroll, S. L., Miller, M. L., Frohnert, P. W., Kim, S. S., & Corbett, J. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01642.1997 · Cited by 328
Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology
Barnard, J. A., Daniel Beauchamp, R., Russell, W. E., Dubois, R. N., & Coffey, R. J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90087-x · Cited by 327
Worthylake, R., Opresko, L. K., & Wiley, H. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8865 · Cited by 325
The WAVE regulatory complex links diverse receptors to the actin cytoskeleton
Chen, B., Brinkmann, K., Chen, Z., Pak, C. W., Liao, Y., Shi, S., Henry, L., Grishin, N. V., Bogdan, S., & Rosen, M. K. (2014) · Cell · doi:10.1016/j.cell.2013.11.048 · Cited by 323
Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma
Ito, Y., Takeda, T., Sakon, M., Tsujimoto, M., Higashiyama, S., Noda, K., Miyoshi, E., Monden, M., & Matsuura, N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1580 · Cited by 321
Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase
Harari, D., Tzahar, E., Romano, J., Shelly, M., Pierce, J., Andrews, G., & Yarden, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1202631 · Cited by 318
Tumor Necrosis Factor-α-converting Enzyme Is Required for Cleavage of erbB4/HER4
Rio, C., Buxbaum, J. D., Peschon, J. J., & Corfas, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10379 · Cited by 309
Beerli, R. R., & Hynes, N. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6071 · Cited by 308
Role of HER2 gene overexpression in breast carcinoma
M�nard, S., Tagliabue, E., Campiglio, M., & Pupa, S. M. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200002)182:2<150::aid-jcp3>3.0.co;2-e · Cited by 303
Yang, Y., Spitzer, E., Meyer, D., Sachs, M., Niemann, C., Hartmann, G., Weidner, K. M., Birchmeier, C., & Birchmeier, W. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.1.215 · Cited by 300
Graus-Porta, D., Beerli, R. R., & Hynes, N. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1182 · Cited by 296
EGFR family: Structure physiology signalling and therapeutic targets †
Burgess, A. W. (2008) · Growth Factors · doi:10.1080/08977190802312844 · Cited by 288
EGF receptor in neoplasia and metastasis
Khazaie, K., Schirrmacher, V., & Lichtner, R. B. (1993) · Cancer and Metastasis Reviews · doi:10.1007/bf00665957 · Cited by 288
Presenilin-dependent γ-Secretase-like Intramembrane Cleavage of ErbB4
Lee, H.-J., Jung, K.-M., Huang, Y. Z., Bennett, L. B., Lee, J. S., Mei, L., & Kim, T.-W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110371200 · Cited by 286
Adam, L., Vadlamudi, R., Kondapaka, S. B., Chernoff, J., Mendelsohn, J., & Kumar, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28238 · Cited by 284
Ligands for ErbB-family receptors encoded by a neuregulin-like gene
Chang, H., Riese II, D. J., Gilbert, W., Stern, D. F., & McMahan, U. J. (1997) · Nature · doi:10.1038/387509a0 · Cited by 281
Neu and its ligands: From an oncogene to neural factors
Peles, E., & Yarden, Y. (1993) · BioEssays · doi:10.1002/bies.950151207 · Cited by 279
ARIA: A Neuromuscular Junction Neuregulin
Fischbach, G. D., & Rosen, K. M. (1997) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.20.1.429 · Cited by 279
Neuregulins are concentrated at nerve-muscle synapses and activate ACh–receptor gene expression
Ahn Jo, S., Zhu, X., Marchionni, M. A., & Burden, S. J. (1995) · Nature · doi:10.1038/373158a0 · Cited by 277
Tzahar, E., Levkowitz, G., Karunagaran, D., Yi, L., Peles, E., Lavi, S., Chang, D., Liu, N., Yayon, A., & Wen, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31521-1 · Cited by 272
Isobe, T., Okuyama, T., Toyoda, H., Komurasaki, T., Uchida, D., Takayama, Y., & Hanada, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7495 · Cited by 269
Williams, C. C., Allison, J. G., Vidal, G. A., Burow, M. E., Beckman, B. S., Marrero, L., & Jones, F. E. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403155 · Cited by 263
Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality
Tidcombe, H., Jackson-Fisher, A., Mathers, K., Stern, D. F., Gassmann, M., & Golding, J. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1436402100 · Cited by 255
Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis
Andrechek, E. R., Hardy, W. R., Siegel, P. M., Rudnicki, M. A., Cardiff, R. D., & Muller, W. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3444 · Cited by 230
HER‐2/ neu Signal Transduction in Human Breast and Ovarian Cancer
Reese, D. M., & Slamon, D. J. (1997) · STEM CELLS · doi:10.1002/stem.150001 · Cited by 229
Defects in pathfinding by cranial neural crest cells in mice lacking the neuregulin receptor ErbB4
Golding, J. P., Trainor, P., Krumlauf, R., & Gassmann, M. (2000) · Nature Cell Biology · doi:10.1038/35000058 · Cited by 181
Muller, W. J., Arteaga, C. L., Muthuswamy, S. K., Siegel, P. M., Webster, M. A., Cardiff, R. D., Meise, K. S., Li, F., Halter, S. A., & Coffey, R. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.10.5726 · Cited by 147
Metadata
- Authors
- Plowman, G. D., Culouscou, J. M., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., Neubauer, M. G., & Shoyab, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1993-03
- Volume
- 90
- Issue
- 5
- Pages
- 1746-1750
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2122788299
- Cited by
- 713
- References
- 24
- FWCI
- 19.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.